Recital 9, Regulation (EU) 2021/139

In forcesince 4 Dec 2020

The Union general export authorisation helps minimise the regulatory burden placed on Union companies exporting goods listed in Annex IV to the Regulation when exporting such medicinal products for legitimate therapeutic purposes.